Lisa Wyman
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Zurzeit ist Lisa Wyman als Vice President-Operations bei Acceleron Pharma, Inc. tätig. Frau Wyman erwarb einen Abschluss an der Tufts University und einen Bachelor-Abschluss am Ithaca College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PEPGEN INC. -.--% | 18.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 29.01.2025 |
| PEPGEN INC. | Direktor/Vorstandsmitglied | 27.03.2025 |
Newage Industries, Inc.
Newage Industries, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures and fabricates flexible plastic tubing and hose and supplies fittings and clamps | Direktor/Vorstandsmitglied | 01.08.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2025 |
| ACCELERON PHARMA INC. | Geschäftsführer | 01.09.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Ithaca College
Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Newage Industries, Inc.
Newage Industries, Inc. Miscellaneous ManufacturingProducer Manufacturing Manufactures and fabricates flexible plastic tubing and hose and supplies fittings and clamps | Producer Manufacturing |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
PepGen Inc.
PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen